ENGN - שווי החברה ברכישה מלאה enGene Holdings Inc.

This chart illustrates that the market value of enGene Holdings Inc. (ENGN) is -130.60, with the business generating revenue by creating non-viral bladder cancer therapies for oncology clinics. The operating model relies on external contractors (CRO and CMO) for clinical testing, while the workforce consists of a tight-knit circle of scientists and contracted production scaling engineers.

Enterprise value assessment is critical for enGene Holdings Inc. (ENGN), as the robotization of gene therapy synthesis requires significant capital expenditures in automation. By analyzing the historical enterprise value trend, an investor can see the sum of market capitalization and debt minus liquid assets, which determines the actual acquisition price of the business and allows for an assessment of the risk of overpayment relative to its technological potential.